The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grabbe, S.
Right arrow Articles by Schwarz, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grabbe, S.
Right arrow Articles by Schwarz, T.

The Journal of Immunology, Vol 155, Issue 9 4207-4217, Copyright © 1995 by American Association of Immunologists


ARTICLES

Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity

S Grabbe, K Steinbrink, M Steinert, TA Luger and T Schwarz
Ludwig Boltzmann Institute for Cell Biology and Immunobiology of the Skin, Department of Dermatology, University of Munster, Germany.

Whereas epidermal Langerhans cells (LC) are thought to be the principal APCs for initiation of contact hypersensitivity (CHS) responses, their role as APC in the effector phase of CHS is still unclear. It is currently thought that LC elicit the CHS response by presenting Ag to trafficking Ag-specific T cells within the skin. To test this hypothesis, we removed the majority of resident LC at the site of CHS challenge by topical application of various steroid creams to one ear in BALB/c mice (> 85% LC depletion). Either 2 days before or 4 days after steroid treatment of the ear, mice were sensitized on the abdomen with the hapten trinitrophenyl and challenged 10 days later at the steroid-pretreated ear. At that time point, direct anti-inflammatory effects of the steroid were no longer present. Surprisingly, CHS responses were markedly stronger at the sites of prior steroid application when compared with vehicle-treated controls, indicating that depletion of most of the resident LC not only fails to impair, but enhances, the expression of CHS significantly. UV irradiation or application of croton oil at the challenge site, as well as systemic steroid application, all of which are alternative methods of diminishing the number of epidermal LC, also significantly up-regulated CHS. In contrast, irritant dermatitis and sensitization or elicitation of CHS in steroid-treated mice at distant sites, as well as delayed- type hypersensitivity responses against the same hapten, were unaffected by topical steroid pretreatment. In conclusion, our data suggest that resident LC are not the relevant APC in the effector phase of CHS and that they may even provide down-regulatory, rather than stimulatory, signals during elicitation of CHS.


This article has been cited by other articles:


Home page
J. Immunol.Home page
C. L. Bennett, M. Noordegraaf, C. A. E. Martina, and B. E. Clausen
Langerhans Cells Are Required for Efficient Presentation of Topically Applied Hapten to T Cells
J. Immunol., November 15, 2007; 179(10): 6830 - 6835.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. R. Mathers, O. A. Tckacheva, B. M. Janelsins, W. J. Shufesky, A. E. Morelli, and A. T. Larregina
In Vivo Signaling through the Neurokinin 1 Receptor Favors Transgene Expression by Langerhans Cells and Promotes the Generation of Th1- and Tc1-Biased Immune Responses
J. Immunol., June 1, 2007; 178(11): 7006 - 7017.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Suto, S. Nakae, M. Kakurai, J. D. Sedgwick, M. Tsai, and S. J. Galli
Mast Cell-Associated TNF Promotes Dendritic Cell Migration
J. Immunol., April 1, 2006; 176(7): 4102 - 4112.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
C. L. Bennett, E. van Rijn, S. Jung, K. Inaba, R. M. Steinman, M. L. Kapsenberg, and B. E. Clausen
Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity
J. Cell Biol., May 23, 2005; 169(4): 569 - 576.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Kess, T. Peters, J. Zamek, C. Wickenhauser, S. Tawadros, K. Loser, G. Varga, S. Grabbe, R. Nischt, C. Sunderkotter, et al.
CD4+ T Cell-Associated Pathophysiology Critically Depends on CD18 Gene Dose Effects in a Murine Model of Psoriasis
J. Immunol., December 1, 2003; 171(11): 5697 - 5706.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Akiba, J. Kehren, M.-T. Ducluzeau, M. Krasteva, F. Horand, D. Kaiserlian, F. Kaneko, and J.-F. Nicolas
Skin Inflammation During Contact Hypersensitivity Is Mediated by Early Recruitment of CD8+ T Cytotoxic 1 Cells Inducing Keratinocyte Apoptosis
J. Immunol., March 15, 2002; 168(6): 3079 - 3087.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
S. Nakae, C. Naruse-Nakajima1, K. Sudo, R. Horai, M. Asano, and Y. Iwakura
IL-1{alpha}, but not IL-1{beta}, is required for contact-allergen-specific T cell activation during the sensitization phase in contact hypersensitivity
Int. Immunol., December 1, 2001; 13(12): 1471 - 1478.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
A. Mehling, K. Loser, G. Varga, D. Metze, T. A. Luger, T. Schwarz, S. Grabbe, and S. Beissert
Overexpression of CD40 Ligand in Murine Epidermis Results in Chronic Skin Inflammation and Systemic Autoimmunity
J. Exp. Med., August 27, 2001; 194(5): 615 - 628.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
H. Hemmi, M. Yoshino, H. Yamazaki, M. Naito, T. Iyoda, Y. Omatsu, S. Shimoyama, J. J. Letterio, T. Nakabayashi, H. Tagaya, et al.
Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factor-{beta}1-dependent cells
Int. Immunol., May 1, 2001; 13(5): 695 - 704.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. M. Engeman, A. V. Gorbachev, R. P. Gladue, P. S. Heeger, and R. L. Fairchild
Inhibition of Functional T Cell Priming and Contact Hypersensitivity Responses by Treatment with Anti-Secondary Lymphoid Chemokine Antibody During Hapten Sensitization
J. Immunol., May 15, 2000; 164(10): 5207 - 5214.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
M. Fukaya
Improvement of Atopic Dermatitis After Discontinuation of Topical Corticosteroid Treatment
Arch Dermatol, May 1, 2000; 136(5): 679 - 680.
[Full Text] [PDF]


Home page
J. Immunol.Home page
C. Curiel-Lewandrowski, K. Mahnke, M. Labeur, B. Roters, W. Schmidt, R. D. Granstein, T. A. Luger, T. Schwarz, and S. Grabbe
Transfection of Immature Murine Bone Marrow-Derived Dendritic Cells with the Granulocyte-Macrophage Colony-Stimulating Factor Gene Potently Enhances Their In Vivo Antigen-Presenting Capacity
J. Immunol., July 1, 1999; 163(1): 174 - 183.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. D. Catalina, P. Estess, and M. H. Siegelman
Selective Requirements for Leukocyte Adhesion Molecules in Models of Acute and Chronic Cutaneous Inflammation: Participation of E- and P- But Not L-Selectin
Blood, January 15, 1999; 93(2): 580 - 589.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
J. M. Weiss, J. Sleeman, A. C. Renkl, H. Dittmar, C. C. Termeer, S. Taxis, N. Howells, M. Hofmann, G. Kohler, E. Schopf, et al.
An Essential Role for CD44 Variant Isoforms in Epidermal Langerhans Cell and Blood Dendritic Cell Function
J. Cell Biol., June 2, 1997; 137(5): 1137 - 1147.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
M. D. Catalina, M. C. Carroll, H. Arizpe, A. Takashima, P. Estess, and M. H. Siegelman
The Route of Antigen Entry Determines the Requirement for L-selectin during Immune Responses
J. Exp. Med., December 15, 1996; 184(6): 2341 - 2352.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.